Viva Biotech Holdings (HKSE:01873) EPS (Basic): HK$0.11 (TTM As of Dec. 2025)


HKSE:01873 Viva Biotech Holdings HKSE:01873
57 GF Score
Price HK$1.10
GF Value HK$0.78
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Viva Biotech Holdings EPS (Basic)?

Viva Biotech Holdings HKSE:01873 +1.85% 57 EPS (Basic) is HK$0.11 as of Dec. 2025. GuruFocus rates HKSE:01873 with a GF Score™ of 57/100 and a GF Value™ of HK$0.78 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Viva Biotech Holdings's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was HK$0.04. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.11.

Viva Biotech Holdings's EPS (Diluted) for the six months ended in Dec. 2025 was HK$0.04. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.10.

Viva Biotech Holdings's EPS without NRI for the six months ended in Dec. 2025 was HK$0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 0.08.

During the past 3 years, the average EPS without NRI Growth Rate was -22.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 10 years, Viva Biotech Holdings's highest 3-Year average EPS without NRI Growth Rate was 135.10% per year. The lowest was -22.70% per year. And the median was 18.50% per year.

Viva Biotech Holdings  (HKSE:01873) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Viva Biotech Holdings EPS (Basic) Related Terms

Viva Biotech Holdings EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Viva Biotech Holdings's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viva Biotech Holdings EPS (Basic) Chart

Viva Biotech Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.18 -0.31 -0.07 0.09 0.11

Viva Biotech Holdings Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.07 0.05 0.03 0.07 0.04
HKSE:01873
57GF Score
Viva Biotech Holdings HKSE:01873
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viva Biotech Holdings EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Viva Biotech Holdings's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(242.775-0)/2110.715
=0.12

Viva Biotech Holdings's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(108.214-0)/2110.248
=0.05

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of HK$0.11 mean?
Viva Biotech Holdings (HKSE:01873) has a EPS (Basic) of HK$0.11 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Viva Biotech Holdings and its competitors.
Is Viva Biotech Holdings' EPS (Basic) too high?
Viva Biotech Holdings' current EPS (Basic) is HK$0.11. Overall, Viva Biotech Holdings has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Viva Biotech Holdings' EPS (Basic) compare to VRTX and REGN?
Viva Biotech Holdings' EPS (Basic) of HK$0.11 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Viva Biotech Holdings and its competitors. Viva Biotech Holdings's current EPS (Basic) is HK$0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viva Biotech Holdings stock overvalued right now?
Based on GuruFocus' analysis, Viva Biotech Holdings (HKSE:01873) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.78, compared to a current price of HK$1.10 — trading 41% above its estimated fair value. The current EPS (Basic) is HK$0.11. Viva Biotech Holdings' overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Viva Biotech Holdings (HKSE:01873), the current EPS (Basic) is HK$0.11 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Viva Biotech Holdings (HKSE:01873) Overvalued in 2026?

Based on GuruFocus' analysis, Viva Biotech Holdings stock appears to be overvalued. The current stock price of HK$1.10 is trading 41% above its estimated GF Value™ of HK$0.78. GuruFocus considers Viva Biotech Holdings to be Significantly Overvalued.

Key valuation signals for HKSE:01873:

  • EPS (Basic): HK$0.11
  • GF Value™: HK$0.78 vs. price of HK$1.10 (41% above fair value)
  • GF Score™: 57/100 with 6 warning signs

No single metric tells the full story. See the HKSE:01873 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Viva Biotech Holdings Business Description

Other Exchanges VBIZF:USAVB0:Germany
Address 735 Ziping Road, Pudong New District, Zhoupu Town, Shanghai, CHN, 201318
Viva Biotech Holdings is engaged in providing the structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development. The company operates in three reportable segments, Drug Discovery Services providing structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development; Contract Development Manufacture Organisation providing contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations; and commercialisation services; and Viva BioInnovator making strategic investments in biotechnology startup companies.
57GF Score

Get the complete analysis for HKSE:01873

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$1.10
Price
HK$0.78
GF Value